# Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

> **NCT04249284** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 18 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986165
- **DRUG:** BMS-986165 prototype 1
- **DRUG:** BMS-986165 prototype 2

## Key facts

- **NCT ID:** NCT04249284
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-06
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04249284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04249284, "Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04249284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*